209 related articles for article (PubMed ID: 35224661)
1. Exposure to the mycotoxin deoxynivalenol reduces the transport of conjugated bile acids by intestinal Caco-2 cells.
Wang J; Bakker W; Zheng W; de Haan L; Rietjens IMCM; Bouwmeester H
Arch Toxicol; 2022 May; 96(5):1473-1482. PubMed ID: 35224661
[TBL] [Abstract][Full Text] [Related]
2. Ribotoxin deoxynivalenol induces taurocholic acid malabsorption in an in vitro human intestinal model.
Wang J; Sijs B; Bakker W; de Haan L; Bouwmeester H
Toxicol Lett; 2023 Jul; 383():54-63. PubMed ID: 37315771
[TBL] [Abstract][Full Text] [Related]
3. Deoxynivalenol increases pro-inflammatory cytokine secretion and reduces primary bile acid transport in an inflamed intestinal in vitro co-culture model.
Wang J; Bakker W; de Haan L; Bouwmeester H
Food Res Int; 2023 Nov; 173(Pt 1):113323. PubMed ID: 37803634
[TBL] [Abstract][Full Text] [Related]
4. Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo.
De Bruijn VMP; Te Kronnie W; Rietjens IMCM; Bouwmeester H
ALTEX; 2024 Jan; 41(1):20-36. PubMed ID: 37528756
[TBL] [Abstract][Full Text] [Related]
5. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
[TBL] [Abstract][Full Text] [Related]
6. Combinatory effects of cereulide and deoxynivalenol on in vitro cell viability and inflammation of human Caco-2 cells.
Beisl J; Pahlke G; Abeln H; Ehling-Schulz M; Del Favero G; Varga E; Warth B; Sulyok M; Abia W; Ezekiel CN; Marko D
Arch Toxicol; 2020 Mar; 94(3):833-844. PubMed ID: 32065293
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs.
Fang W; Zhang L; Meng Q; Wu W; Lee YK; Xie J; Zhang H
J Anim Sci; 2018 Nov; 96(11):4743-4754. PubMed ID: 30102377
[TBL] [Abstract][Full Text] [Related]
8. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
10. Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.
Ferrebee CB; Li J; Haywood J; Pachura K; Robinson BS; Hinrichs BH; Jones RM; Rao A; Dawson PA
Cell Mol Gastroenterol Hepatol; 2018; 5(4):499-522. PubMed ID: 29930976
[TBL] [Abstract][Full Text] [Related]
11. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
12. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models.
Zhang Y; LaCerte C; Kansra S; Jackson JP; Brouwer KR; Edwards JE
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226620
[TBL] [Abstract][Full Text] [Related]
13. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Oral Absorption and Liver Distribution of Polymeric Nanoparticles through Traveling the Enterohepatic Circulation Pathways of Bile Acid.
Wang L; Liu Q; Hu X; Zhou C; Ma Y; Wang X; Tang Y; Chen K; Wang X; Liu Y
ACS Appl Mater Interfaces; 2022 Sep; 14(37):41712-41725. PubMed ID: 36069201
[TBL] [Abstract][Full Text] [Related]
15. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations.
Sergent T; Parys M; Garsou S; Pussemier L; Schneider YJ; Larondelle Y
Toxicol Lett; 2006 Jul; 164(2):167-76. PubMed ID: 16442754
[TBL] [Abstract][Full Text] [Related]
16. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
[TBL] [Abstract][Full Text] [Related]
17. Role of the intestinal bile acid transporters in bile acid and drug disposition.
Dawson PA
Handb Exp Pharmacol; 2011; (201):169-203. PubMed ID: 21103970
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of a mycotoxin, deoxynivalenol, and a trace metal, cadmium, alone or in a mixture on the intestinal barrier.
Luo S; Terciolo C; Bracarense APFL; Payros D; Pinton P; Oswald IP
Environ Int; 2019 Nov; 132():105082. PubMed ID: 31400600
[TBL] [Abstract][Full Text] [Related]
19. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.
Beaudoin JJ; Bezençon J; Sjöstedt N; Fallon JK; Brouwer KLR
Toxicol Sci; 2020 Jul; 176(1):34-35. PubMed ID: 32294204
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.
Thomas C; Landrier JF; Gaillard D; Grober J; Monnot MC; Athias A; Besnard P
Gut; 2006 Sep; 55(9):1321-31. PubMed ID: 16484503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
